Compare ARK Genomic Revolution ETF (ARKG) vs Celestica Inc (CLS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Celestica Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Celestica Inc trades at $351.35 (market cap $41.29B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Celestica Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | CLS | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $472.40 |
52-Week Low | $23.09 | $156.91 |
Market Cap | — | $41.29B |
Enterprise Value | — | $41.69B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
CLS trades at $359.85, up 1.43% today, with a bullish technical outlook and strong earnings momentum after beating estimates for three consecutive quarters. The stock shows robust profitability with a 52.45% ROE and 6.95% net margin, supported by positive analyst sentiment and a $440.10 consensus price target. Recent leadership changes and raised revenue guidance to $19 billion highlight growth prospects in AI and cloud infrastructure.
Outlook remains positive driven by AI demand and earnings beats, but high valuation multiples (P/E 43.62) and competitive pressures pose risks. Investors should monitor Q2 2026 results on July 27, 2026, for confirmation of growth trajectory amid margin challenges noted by analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Celestica Inc
Celestica provides supply chain and manufacturing solutions for global technology companies. It specializes in high-complexity assembly and platform solutions for AI data centers, aerospace, and medical markets.
Read more on CLS →
